Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
Source: BMJ - Category: General Medicine Source Type: research
More News: Bile Duct Cancer | Cholangiocarcinoma | Diabetes | Diabetes Type 2 | Endocrinology | General Medicine | Incretin Therapy | Study